AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 112 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,607,647 | +1918.4% | 642,652 | +1010.6% | 0.00% | – |
| Q3 2022 | $476,000 | +244.9% | 57,864 | +174.7% | 0.00% | – |
| Q2 2022 | $138,000 | +62.4% | 21,067 | +38.8% | 0.00% | – |
| Q1 2022 | $85,000 | -93.0% | 15,178 | -94.1% | 0.00% | – |
| Q4 2021 | $1,211,000 | -30.4% | 258,108 | -8.4% | 0.00% | – |
| Q3 2021 | $1,741,000 | -23.0% | 281,667 | -17.8% | 0.00% | -100.0% |
| Q2 2021 | $2,260,000 | +608.5% | 342,842 | +686.3% | 0.00% | – |
| Q1 2021 | $319,000 | +31.3% | 43,603 | +3.6% | 0.00% | – |
| Q4 2020 | $243,000 | -63.3% | 42,080 | -62.3% | 0.00% | – |
| Q3 2020 | $663,000 | +77.3% | 111,607 | +53.8% | 0.00% | – |
| Q2 2020 | $374,000 | – | 72,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |